March 06, 2005
An Indiana company will pay $7.2 million to settle claims that it sold mice that did not meet researchers’ specifications to the National Institute on Aging.
The government contended that the company failed to disclose repeated tests showing that a rodent strain it provided had been compromised
The U.S. attorney’s office agreed in the settlement not to file suit under the False Claims Act, a statute that allows the government to recover triple the actual damages as well as other penalties.
The Washington Post reported the settlement on March 2, 2005